Companies / AVR

ANTERIS TECHNOLOGIES GLOBAL CORP.

ASX:AVRHealth Care Equipment & Services
97.5M shares on issueASX (delayed) · as of 28 July 2026$11.50price · delayed$1.11Bmarket cap · indicative
B
Dilution grade

7 cash raises in 24 months

Cash runwayno data — no longer lodges quarterly cash reports (4C/5B)
Share-count growth (24m)-20.7%
Raise cadence (24m)7 cash raises
Options & rights overhangno data — options line data suspect
In-the-money supplyno data — options line data suspect
Pending proposed issuesnone

ANTERIS TECHNOLOGIES GLOBAL CORP.'s ordinary share count declined 20.7% between May 2024 and July 2026 to 15M shares. The company raised capital seven times in the 24‑month window for total disclosed proceeds of A$724.5M, most recently via an At‑the‑market offering (Sales Agreement / ATM) in May 2026. Options overhang data is omitted because the outstanding option-line data on record is treated as suspect. The company no longer lodges quarterly cash reports, so no quarterly cash balance or funding‑runway figure is on record. There are no proposed securities issues (Appendix 3B) pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
—
Max option dilution · omitted
—
ITM option dilution
5
Raises · last 12 months
—
Cash cover · stale filings

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 97.5M per ASX (delayed) (28 July 2026).
37.2M59.3M81.4MDec 24Sept 25July 26Cash raise · 25 May 2026Cash raise · 20 Jan 2026Cash raise · 20 Jan 2026Cash raise · 28 Oct 2025Cash raise · 23 Oct 2025Cash raise · 7 Apr 2025Cash raise · 19 Dec 2024

Cash runway

—
stale Last quarterly cash report is more than 12 months old (quarter ended 30 Sept 2024) — runway is not computed from stale filings.
$-844k available cash reported at 30 Sept 2024.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 Sept 2024.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
23 July 20263G · unquotedAVR : CHESS DEPOSITARY INTERESTS 1:115.2MAppendix 3G
14 July 20262A · quoted issueAVR : CHESS DEPOSITARY INTERESTS 1:115.2MAppendix 2A
13 July 20263G · unquotedCHESS DEPOSITARY INTERESTS 1:115.2MAppendix 3G
1 July 20263H · cancellationAVR : CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED15.2MAppendix 3H
24 June 20263G · unquotedAVR : CHESS DEPOSITARY INTERESTS15.2MAppendix 3G
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

7 cash raises in the last 24 months · 5 in the last 12 months

—
At-the-market offering (Sales Agreement / ATM)
25 May 2026 ACTIVE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

Options summary omitted. options line data suspect

Director dealings

DateDirectorTypeSharesOptionsValueSource
7 June 2026David RobertsOther18k——3Y notice
7 June 2026Gregory Simon MossOther18k——3Y notice
2 June 2026Susan KnightBuy11k—$102k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

23 July 2026Notification regarding unquoted securities - AVR
14 July 2026Application for quotation of securities - AVR
13 July 2026Notification regarding unquoted securities - AVR
3 July 2026Statement of CDIs on issue - AVR
1 July 2026Form S-3 Registration Statement
1 July 2026Notification of cessation of securities - AVR
24 June 2026Notification regarding unquoted securities - AVR
24 June 2026Application for quotation of securities - AVR
21 June 2026Change of Director's Interest Notice
8 June 2026PARADIGM - French Regulatory Clearance
5 June 2026Change of Director's Interest Notice
5 June 2026Statement of CDIs on issue - AVR
2 June 2026Notification of cessation of securities - AVR
24 May 2026$PProspectus Supplement and Sales Agreement
18 May 2026Initial Director's Interest Notice x 2
12 May 2026Board Appointments
12 May 2026$PResults for the First Quarter of 2026
12 May 2026$PQuarterly Results Announcement and SEC Form 10-Q
5 May 2026$PFirst US Patients Treated in Global Pivotal PARADIGM Trial
5 May 2026Statement of CDIs on issue - AVR

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.